No information available about the pharmacokinetic parameters in children.
No information is present at this moment.
No information is present at this moment.
| Nausea and vomiting, travel sickness |
|---|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Do not give to children aged under 1 year because the sedative effect could cause periods of respiratory arrest during sleep.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Piperazine derivatives | ||
|---|---|---|
| R06AE07 | ||
| Other antihistamines for systemic use | ||
|---|---|---|
| R06AX26 | ||
| R06AX13 | ||